Abstract
SAT370 - Understanding the dynamics of HBsAg decline through model-informed drug development (MIDD) of JNJ-3989 and JNJ-6379 for the treatment of chronic hepatitis B virus infection (CHB)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have